| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/16/2004 | EP1315731B1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 06/16/2004 | EP1257267B1 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms |
| 06/16/2004 | EP1255751B1 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors |
| 06/16/2004 | EP1235777B1 Vitamin d analogues |
| 06/16/2004 | EP1218401B1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
| 06/16/2004 | EP1194411B1 Benzoylpyridazines |
| 06/16/2004 | EP1144425B1 Derivatives of monosaccharides as cell adhesion inhibitors |
| 06/16/2004 | EP1119570B1 Tricyclic delta3-piperidines as pharmaceuticals |
| 06/16/2004 | EP1061947B1 Stabilized aqueous glucagon solutions comprising detergents |
| 06/16/2004 | EP0973730B1 Calcilytic compounds |
| 06/16/2004 | CN1505640A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/16/2004 | CN1505638A Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
| 06/16/2004 | CN1505636A Pharmaceutically active uridine esters |
| 06/16/2004 | CN1505631A Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligands |
| 06/16/2004 | CN1505630A Pyrazolo[1,5-a]pyridines and medicaments containing thereof |
| 06/16/2004 | CN1505618A Dimeric isoflavones |
| 06/16/2004 | CN1505613A Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents |
| 06/16/2004 | CN1505603A Substituted benzoic ac id derivatives exhibiting nf-ª—b inhibiting activity |
| 06/16/2004 | CN1505524A Immunopotentiators |
| 06/16/2004 | CN1505517A Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| 06/16/2004 | CN1505514A Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 06/16/2004 | CN1505505A Composition for administration to mucosa and containing coenzyme Q as active ingredient |
| 06/16/2004 | CN1505502A Fibrate-statin combinations with reduced fed-fasted effects |
| 06/16/2004 | CN1504752A Vaughan Tristan J. |
| 06/16/2004 | CN1504238A Medicine for treating diabetes |
| 06/16/2004 | CN1504234A Traditional Chinese medicine compositions for weight reduction , beauty and body enhancement |
| 06/16/2004 | CN1504233A Lucid ganoderma oral liquid |
| 06/16/2004 | CN1504227A Tangnaikang granula and its preparing process |
| 06/16/2004 | CN1504209A Process of healthcare capsule of edible cactus |
| 06/16/2004 | CN1504198A Compound containing arsenic for prevention and treatment of cough and gasp , and reducing weight and fat |
| 06/16/2004 | CN1504197A Nutritious drinking water containing sodium fluoride for infant |
| 06/16/2004 | CN1504190A Pharmaceutical composition containing levo-histidine for treating diabetes |
| 06/16/2004 | CN1504187A Pharmaceutical composition containing fenofibrate with high efficacy for hyperlipemia, its preparation method and use |
| 06/16/2004 | CN1504128A Nutritious drinking water containing nicotinic acid for infant |
| 06/16/2004 | CN1504127A Nutritious drinking water containing ferric lactate for infant |
| 06/16/2004 | CN1504126A Drinking water containing microelement for infant< |
| 06/16/2004 | CN1504125A Drinking water containing lysine for infant< |
| 06/16/2004 | CN1504124A Nutritious drinking water containing vitamin B2 for infant |
| 06/16/2004 | CN1504123A Nutritious drinking water containing vitamin D for infant |
| 06/16/2004 | CN1504122A Nutritious drinking water containing lecithin for infant |
| 06/16/2004 | CN1504121A Nutritious drinking water containing vitamin A for infant |
| 06/16/2004 | CN1504120A Drinking water containing glutamic acid for infant |
| 06/16/2004 | CN1504119A Nutritious liquid containing calcium for children |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/16/2004 | CN1153584C Diabetes capsule |
| 06/16/2004 | CN1153579C Buccal tablets for activating intelligent genes and increasing intelligence quotient |
| 06/16/2004 | CN1153572C Mineral salt composition and its use |
| 06/15/2004 | US6750353 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline form |
| 06/15/2004 | US6750252 Tri-substituted phenyl derivatives and analogues |
| 06/15/2004 | US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |
| 06/15/2004 | US6750239 Useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 06/15/2004 | US6750234 Regression of skin tumors, skin homeostases and remodeling, epidermal barrier development, hair growth, and especially wound healing. |
| 06/15/2004 | US6750232 2-aminopyridine compounds and use thereof as drugs |
| 06/15/2004 | US6750217 Anticancer agents; cardiovascular disorders; kinase inhibitor |
| 06/15/2004 | US6750202 Inhibitors of procollagen c-proteinase (pcp), for treating fibrosis of the liver |
| 06/15/2004 | US6750055 Implantable artificial organ and physiological monitoring system |
| 06/15/2004 | US6750026 To diagnose diseases relating to under- or over-expression of hfgan72 receptor ligands; for treatment of obesity, diabetes, anorexia nervosa, bulimia, cachexia, chronic renal failure, congestive heart failure |
| 06/15/2004 | US6749870 Compositions and methods for the control of smoking |
| 06/15/2004 | US6749851 Applying radiation |
| 06/15/2004 | US6749849 Method for producing arachidonic acid |
| 06/15/2004 | US6749587 Modular infusion device and method |
| 06/15/2004 | CA2088334C Fast dissolving tablet and its production |
| 06/10/2004 | WO2004049095A2 Betaine and salicylic acid compositions |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048565A1 Apoptosis-associated protein and use thereof |
| 06/10/2004 | WO2004048512A2 Novel proteins and nucleic acids encoding same |
| 06/10/2004 | WO2004048419A1 Method of classifying, purifying and using fenugreek seeds |
| 06/10/2004 | WO2004048391A1 Silicon compounds to be used as ligands for retinoid receptors |
| 06/10/2004 | WO2004048379A1 Xanthine compound |
| 06/10/2004 | WO2004048366A1 2-oxoindoline derivatives |
| 06/10/2004 | WO2004048356A1 Inorganic ionic molecular crystal |
| 06/10/2004 | WO2004048352A2 2-cyanopyrrolidines and their analogues as dpp-iv inhibitors |
| 06/10/2004 | WO2004048349A1 Farnesoid x receptor agonists |
| 06/10/2004 | WO2004048341A1 Novel heteroaryl derivative |
| 06/10/2004 | WO2004048338A1 Noncyclic 1,3-dicarbonyl compounds as dual ppar agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 06/10/2004 | WO2004048334A1 Phenyl substituted piperidine compounds for use as ppar activators |
| 06/10/2004 | WO2004048333A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 06/10/2004 | WO2004048319A1 Novel benzamide compounds for use in mch receptor related disorders |
| 06/10/2004 | WO2004047926A1 Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone |
| 06/10/2004 | WO2004047855A2 Proteins involved in the regulation of energy homeostasis |
| 06/10/2004 | WO2004047831A2 Use of a pparalpha agonist and metformin for decreasing the serum triglycerides |
| 06/10/2004 | WO2004047817A1 Pde4 and pde3/4 inhibitors for use in the treatment of cachexia |
| 06/10/2004 | WO2004047565A1 Agent for foods, drinks or medical uses containing body temperature-elevating amino acid |
| 06/10/2004 | WO2004037776A3 Novel compounds and their use as prar-modulators |
| 06/10/2004 | WO2004032836A3 Antidiabetic beta-amino heterocylcic dipeptidyl peptidase inhibitors |
| 06/10/2004 | WO2004018429A3 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/10/2004 | WO2004004698A3 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/10/2004 | WO2004004633A3 Use of tnfalpha antibodies and another drug |
| 06/10/2004 | WO2004003235A3 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 06/10/2004 | WO2003084943A9 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003072027A3 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 06/10/2004 | WO2003070970A3 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 06/10/2004 | WO2003048116A3 Esters and amides as ppar-alpha agonists ____________ |
| 06/10/2004 | WO2003043972A3 Functional acylglycerides |
| 06/10/2004 | WO2002090600A3 A method for regulating immune function in primates using the foxp3 protein |
| 06/10/2004 | WO2002053091A3 Medicinal combination of a biguanine (metformin) and arginine |
| 06/10/2004 | US20040111763 for introducing DNA into organisms which produce large amounts of oils; genetic engineering; for animal feed, foods, cosmetics and pharmaceuticals; kits |
| 06/10/2004 | US20040110956 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 06/10/2004 | US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide |